About Megnosis
Megnosis is a Healthcare company based in Daejeon (South Korea) founded in 2020. Medical device for dementia treatment developed using EEG-based scalp stimulation. Its chief executive, as recorded, is Lee Soon-hyuk. Megnosis offers products and services including BRAINSPECT20, BRAINCURE20, Reactive EEG, and tCS. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity in India is (μ£Ό)λ©κ·Έλ Έμμ€ (U99999MH1977PLC010754).
Company details
Megnosis was founded in 2020 in Daejeon, South Korea, within the medical device sector focused on neurology. An EEG-based scalp device is developed to treat dementia symptoms. Brain cells are activated by the device through transcranial electrical stimulation combined with magnetic fields. Operations center on device innovation for symptom alleviation in dementia patients, with activities based in South Korea.
- Headquarters Daejeon, South Korea
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website megnosis.com
- Legal Name (주)메그노시스
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of Megnosis
Megnosis operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of Megnosis
Megnosis offers a comprehensive portfolio of products and services, including BRAINSPECT20, BRAINCURE20, Reactive EEG, and tCS.
Device for EEG-based diagnosis of cognitive disorders like dementia.
Tool for brain stimulation to treat and prevent conditions like depression.
Method for active measurement of brain functions to improve diagnostics.
Transcranial current stimulation for activating brain cells in therapy.
People of Megnosis
1 people are tracked at Megnosis (1 in leadership).
| Name | Role | Group |
|---|---|---|
Lee Soon-hyuk | CEO | Leadership |
Complete people profiles for Megnosis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of Megnosis
The website of Megnosis (megnosis.com) receives about 2.5K visits a month.
- Monthly visits2.5K
▲ 72.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Megnosis
Complete news archive for Megnosis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Megnosis
Megnosis was founded in 2020.
Megnosis is headquartered in Daejeon, South Korea.
Lee Soon-hyuk is the CEO of Megnosis, as recorded in our data.
Megnosis was founded in 2020 in Daejeon, South Korea, within the medical device sector focused on neurology. An EEG-based scalp device is developed to treat dementia symptoms. Brain cells are activated by the device through transcranial electrical stimulation combined with magnetic fields. Operations center on device innovation for symptom alleviation in dementia patients, with activities based in South Korea.
Megnosis offers BRAINSPECT20, BRAINCURE20, Reactive EEG, and tCS.
Megnosis operates through ,.